Pacific Biosciences Of California | PACB - Interest Expense On Debt


Pacific Biosciences Of California reported $1.74M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Agilent USD 25M 0 Mar/2026
Bruker USD 8.1M 11.9M Dec/2025
Danaher USD 63M 8M Mar/2026
General Electric Aerospace USD 496M 271M Dec/2025
Illumina USD 26M 1000K Dec/2025
Myriad Genetics USD 4.4M 600K Dec/2025
Pacific Biosciences Of California USD 1.74M 1000 Dec/2025
Quidel USD 5.63B 5.58B Mar/2026
Revvity USD 24.72M 1.2M Mar/2026
Roche Holding CHF 304M 7.5M Jun/2025
Standard Biotools USD 5K 5K Dec/2025
Thermo Fisher Scientific USD 354M 11M Mar/2026
Waters USD 42M 33.38M Mar/2026